Silico is building the next generation Decision Intelligence platform that is powering better decisions at some of the world's largest organisations. Leveraging the power of Causal Decision Models and integrating seamlessly with your data & workflows, we help you to deliver better decisions on demand.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $4.55M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 19.04.2023 | MK Venture... | mk-vc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.03.2022 | Seed | $4.55M | - |
Mentions in press and media 8
| Date | Title | Description |
| 09.05.2023 | 94% of UK businesses trust technology to make crucial decisions | A number of changes over the last few years have presented additional and very important challenges that have affected the work environment and development in uncertain and unstable macroeconomic conditions. Moreover, companies face additio... |
| 03.03.2022 | Transforming the way businesses make decisions, London’s no-code startup rakes in £3.4 million | London-based AI-powered decision-making platform Silico has raised £3.4 million funding. The round was led by Berlin-based early-stage VC firm Join Capital, with participation from existing investor Forward Partners and high-profile angel i... |
| 03.03.2022 | AI-powered startup Silico raises £3.4m | Silico, an AI-powered decision-making platform has announced the completion of a £3.4m seed round of investments, led by German VC Join Capital. Existing investors Forward Partner also participated in the latest round, along with ‘high-prof... |
| 03.03.2022 | Silico Raises £3.4M in Seed Funding | Silico, a London, UK-based AI-powered decision making platform provider, raised £3.4M in Seed funding. The round was led by Join Capital with participation from Forward Partners and unnamed angels. As part of the terms of the seed round, Jo... |
| 05.06.2018 | In silico drug developer Nimbus collects $65M in new funding round | Nimbus Therapeutics has reined in $65 million in new capital to fund its virtual drug discovery and development pipeline and expand into new targets in immunology, oncology and metabolic diseases. Each of the company’s previous investors pa... |
| 05.06.2018 | In silico drug developer Nimbus collects $65M in new funding round W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Nimbus Therapeutics has reined in $65 million in new capital to fund its virtual drug discovery and development pipeline and expand into new targets in immunology, oncology and metabolic diseases. Sponsored by Agilent Technologies How would... |
| - | 145 интересных no-code / low-code стартапов | Меня зовут Александр. Я занимаюсь туристическим бизнесом (domik.travel) и веду блог про бизнес и маркетинг в телеграм канале (https://t.me/burtovoyorg) В последнее время меня заинтересовала тема no-code и я начал активно в неё погружаться. ... |
| - | Transforming the way businesses make decisions, London’s no-code startup rakes in £3.4 million | London-based AI-powered decision-making platform Silico has raised £3.4 million funding. The round was led by Berlin-based early-stage VC firm Join Capital, with participation from existing investor Forward Partners and high-profile angel i... |